Root Financial Partners
RYTM icon

Root Financial Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Root Financial Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$286 Buy
+3
New +$320 ﹤0.01% 3414
2026
Q2 		– Sell
-31
Closed -$2.7K – 2623
2026
Q1 		$2.7K Sell
31
-12
-28% -$1.17K ﹤0.01% 2188
2025
Q4 		$4.6K Buy
+43
New +$4.56K ﹤0.01% 1786

Other funds holding RYTM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Root Financial Partners's RYTM Position: Q3 2026 in Review

Root Financial Partners opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 3 shares worth $286. The stake represents ﹤0.01% of the portfolio and ranks #3414 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in RYTM as recently as Q1 2026.

Root Financial Partners first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.6K in Q4 2025. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Root Financial Partners held 3 shares of Rhythm Pharmaceuticals worth $286 as of Q3 2026.
  • Rhythm Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3414 holding.
  • Root Financial Partners first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Rhythm Pharmaceuticals position peaked at $4.6K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.